Undifferentiated Carcinoma Clinical Trials Undifferentiated Carcinoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
Conditions:   Thyroid Neoplasms;   Poorly Differentiated and Undifferentiated Thyroid Cancer;   Differentiated Thyroid Cancer Intervention:   Drug: CUDC-907 Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2016 Category: Research Source Type: clinical trials

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
Conditions:   Thyroid Neoplasms;   Poorly Differentiated and Undifferentiated Thyroid Cancer;   Differentiated Thyroid Cancer Intervention:   Drug: CUDC-907 Sponsor:   National Cancer Institute (NCI) Recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2016 Category: Research Source Type: clinical trials

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
Conditions:   Thyroid Neoplasms;   Poorly Differentiated and Undifferentiated Thyroid Cancer;   Differentiated Thyroid Cancer Intervention:   Drug: CUDC-907 Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2016 Category: Research Source Type: clinical trials